IRIS
GALLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.503
NA - Nord America 6.534
AS - Asia 5.089
SA - Sud America 856
Continente sconosciuto - Info sul continente non disponibili 485
AF - Africa 73
OC - Oceania 8
AN - Antartide 1
Totale 24.549
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.150
US - Stati Uniti d'America 6.355
SG - Singapore 1.724
IT - Italia 1.539
CN - Cina 1.073
IE - Irlanda 1.011
HK - Hong Kong 769
BR - Brasile 702
VN - Vietnam 616
GB - Regno Unito 405
DE - Germania 338
UA - Ucraina 284
KR - Corea 227
JP - Giappone 173
IN - India 171
SE - Svezia 140
AT - Austria 133
TR - Turchia 118
FR - Francia 116
FI - Finlandia 102
CA - Canada 81
GR - Grecia 71
NL - Olanda 68
AR - Argentina 65
BD - Bangladesh 56
MX - Messico 34
BE - Belgio 25
PL - Polonia 24
EC - Ecuador 23
IQ - Iraq 22
CO - Colombia 21
ES - Italia 19
ID - Indonesia 17
MA - Marocco 17
PK - Pakistan 17
PY - Paraguay 16
ZA - Sudafrica 16
CR - Costa Rica 14
CZ - Repubblica Ceca 12
PH - Filippine 12
IR - Iran 11
JM - Giamaica 11
MY - Malesia 11
UZ - Uzbekistan 11
KE - Kenya 9
NI - Nicaragua 9
RO - Romania 9
AU - Australia 8
CH - Svizzera 8
CL - Cile 8
UY - Uruguay 8
DZ - Algeria 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
EG - Egitto 6
GT - Guatemala 6
LT - Lituania 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
EE - Estonia 5
HN - Honduras 5
IL - Israele 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
KZ - Kazakistan 4
PT - Portogallo 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TN - Tunisia 4
AM - Armenia 3
BO - Bolivia 3
ET - Etiopia 3
EU - Europa 3
JO - Giordania 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
NP - Nepal 3
PE - Perù 3
SC - Seychelles 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
HR - Croazia 2
HU - Ungheria 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
SM - San Marino 2
SV - El Salvador 2
AQ - Antartide 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
CG - Congo 1
Totale 24.051
Salva come PNG Salva come JPEG
Città #
Moscow 2.579
Dublin 1.010
Singapore 783
Hong Kong 748
San Jose 716
Santa Clara 663
Ashburn 534
Jacksonville 450
Council Bluffs 422
Chandler 387
Seoul 222
Ho Chi Minh City 202
Naples 188
Hefei 184
Milan 159
Hanoi 149
Beijing 144
New York 131
Princeton 129
Los Angeles 127
Vienna 117
Caserta 115
Ann Arbor 113
Roxbury 105
Bengaluru 99
Medford 94
Dallas 92
The Dalles 89
Rome 76
São Paulo 65
Bremen 62
Wilmington 60
Munich 59
Woodbridge 57
Boardman 53
Nanjing 46
Norwalk 42
San Mateo 40
Cambridge 39
Orem 37
Haiphong 34
Chicago 32
Da Nang 32
Napoli 32
Atlanta 30
Des Moines 27
Nuremberg 27
London 26
Memphis 26
Phoenix 26
Amsterdam 25
Houston 25
Tokyo 25
Aversa 23
Brussels 23
Montreal 21
Quarto 21
San Francisco 21
Denver 20
Falkenstein 20
Frankfurt am Main 20
Jinan 20
Miano 20
Turin 20
Warsaw 20
Brooklyn 17
Carrboro 17
Chennai 17
Rio de Janeiro 16
Shenyang 16
Thái Bình 16
Brasília 15
Istanbul 15
Mountain View 15
North Bergen 15
Stockholm 15
Guangzhou 14
Hải Dương 14
Manchester 14
Turku 14
Belo Horizonte 13
Genoa 13
Guayaquil 13
Kochi 13
Miami 13
Newark 13
San José 13
Shanghai 13
Toronto 13
Verona 13
Curitiba 12
Boston 11
Guarulhos 11
Helsinki 11
Redwood City 11
Reggio Emilia 11
Afragola 10
Auburn Hills 10
Buffalo 10
Caivano 10
Totale 12.470
Salva come PNG Salva come JPEG
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 676
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 371
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 220
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 217
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 211
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 210
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 202
Advantages of QBI in TBSS analyses. 196
Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis 191
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 187
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 187
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 187
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 185
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 183
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 181
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 180
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 180
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 178
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 172
Frontotemporal cortical thinning in amyotrophic lateral sclerosis. 171
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 170
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 169
A Combined Use of Radiomics and Connectomics to Classify Sex and Age in Healthy Subjects: The New “Radioconnectomics” Paradigm 168
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 167
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis. 162
Assessing response to interferon-β in a multicenter dataset of patients with MS 161
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 161
A multiparametric brain and cord MR imaging study of a patient with Hirayama disease. 160
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 160
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 156
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 154
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 154
Quality of life in women with multiple sclerosis and overactive bladder syndrome 154
Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population 153
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy. 153
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 152
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis 151
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 151
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 151
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 150
Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study 150
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 150
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 149
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 149
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 148
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis 146
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 146
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 146
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab 146
Extra-motor involvement in ALS patients: a cortical thickeness 3T MRI study 145
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 145
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary study. 144
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 144
The role of diet in multiple sclerosis: A review 144
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 144
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 144
T(1) cortical hypointensities and their association with cognitive disability in multiple sclerosis 143
Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study 143
Consensus of algorithms for lesion segmentation in brain MRI studies of multiple sclerosis 142
An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS 142
Functional gradients reveal cortical hierarchy changes in multiple sclerosis 141
Signs and symptoms of COVID-19 in patients with multiple sclerosis 141
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 141
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 141
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study 140
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study 140
Informing MS patients on treatment options: a consensus on the process of consent taking 139
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs 138
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 137
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 137
Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis 136
Proton spectroscopic imaging - Principles and clinical applications in neurology 136
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 136
Clinical and MRI features contributing to the clinico-radiological dissociation in a large cohort of people with multiple sclerosis 135
A real-world study of alemtuzumab in a cohort of Italian patients 135
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study. 133
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 133
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 132
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 132
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution 132
Quality and Quantity of Diffuse and Focal White Matter Disease and Cognitive Disability of Patients with Multiple Sclerosis 132
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 132
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 132
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 131
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: A MAGNIMS Study 131
Multiparametric MRI in a patient with adult-onset leukoencephalopathy with vanishing white matter 131
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 131
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 130
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 130
dVRS and Fatigue: is there a link? Magnetic Resonance retrospective 3T study 130
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 128
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity 128
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: The importance of intrathecal MOG-IgG synthesis 126
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI 126
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability 126
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. 125
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years 125
The relationship between biological sex, cognitive reserve, and cognition in multiple sclerosis 124
Longitudinal assessment of cognitive function in patients with non-relapsing MOG-IgG associated disease 124
Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype 124
Totale 15.853
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022858 0 0 0 35 287 27 25 40 61 65 70 248
2022/20231.778 179 22 32 127 166 132 6 85 941 27 26 35
2023/20241.058 71 38 53 105 262 120 69 29 36 21 107 147
2024/20253.086 22 33 43 91 553 369 414 230 465 369 282 215
2025/202612.738 523 762 711 629 1.065 6.646 912 462 381 276 242 129
2026/20272.413 149 415 928 921 0 0 0 0 0 0 0 0
Totale 24.549